Neuroblastoma
Symptoms, Doctors, Treatments, Advances & More

Learn About Neuroblastoma

View Main Condition: Neural Crest Tumor

What is the definition of Neuroblastoma?

Neuroblastoma is a type of cancer that most often affects children. Neuroblastoma occurs when immature nerve cells called neuroblasts become abnormal and multiply uncontrollably to form a tumor. Most commonly, the tumor originates in the nerve tissue of the adrenal gland located above each kidney. Other common sites for tumors to form include the nerve tissue in the abdomen, chest, neck, or pelvis. Neuroblastoma can spread (metastasize) to other parts of the body such as the bones, liver, or skin.

What are the causes of Neuroblastoma?

Neuroblastoma and other cancers occur when a buildup of genetic mutations in critical genes—those that control cell growth and division (proliferation) or maturation (differentiation)—allow cells to grow and divide uncontrollably to form a tumor. In most cases, these genetic changes are acquired during a person's lifetime and are called somatic mutations. Somatic mutations are present only in certain cells and are not inherited. When neuroblastoma is associated with somatic mutations, it is called sporadic neuroblastoma. It is thought that somatic mutations in at least two genes are required to cause sporadic neuroblastoma. Less commonly, gene mutations that increase the risk of developing cancer can be inherited from a parent. When the mutation associated with neuroblastoma is inherited, the condition is called familial neuroblastoma. Mutations in the ALK and PHOX2B genes have been shown to increase the risk of developing sporadic and familial neuroblastoma. It is likely that there are other genes involved in the formation of neuroblastoma.

What are the different types of Neuroblastoma?
How prevalent is Neuroblastoma?

Neuroblastoma is the most common cancer in infants younger than 1 year. It occurs in 1 in 100,000 children and is diagnosed in about 650 children each year in the United States.

Is Neuroblastoma an inherited disorder?

Most people with neuroblastoma have sporadic neuroblastoma, meaning the condition arose from somatic mutations in the body's cells and was not inherited.

Who are the top Neuroblastoma Local Doctors?
Elite in Neuroblastoma
Hematology | Oncology | Pediatrics
Elite in Neuroblastoma
Hematology | Oncology | Pediatrics
Referral may be required

SJCH Pediatric Hematology & Oncology

3001 W Dr Martin Luther King Jr Blvd, Fl 1, 
Tampa, FL 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Don Eslin is a Hematologist and an Oncologist practicing medicine in Tampa, Florida. Dr. Eslin is rated as an Elite provider by MediFind in the treatment of Neuroblastoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Embryonal Tumor with Multilayered Rosettes, Neuroblastoma, Medulloblastoma, Gliomatosis Cerebri, and Bone Marrow Aspiration. Dr. Eslin is board certified in AB Pediatrics (Pediatric Hematology-Oncology) and AB Pediatrics - Pediatrics. Dr. Eslin is currently accepting new patients.

Elite in Neuroblastoma
Hematology | Oncology
Elite in Neuroblastoma
Hematology | Oncology
Referral may be required

University Of Chicago Medical Center

5841 S Maryland Ave, 
Chicago, IL 
Languages Spoken:
English
Accepting New Patients

Susan Cohn is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Cohn is rated as an Elite provider by MediFind in the treatment of Neuroblastoma. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Cohn is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Neuroblastoma
Hematology | Oncology
Distinguished in Neuroblastoma
Hematology | Oncology
Referral may be required

Levine Children's Hospital

1000 Blythe Blvd., 
Charlotte, NC 
Languages Spoken:
English, Spanish
Accepting New Patients
Offers Telehealth

Javier Oesterheld is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Oesterheld is rated as a Distinguished provider by MediFind in the treatment of Neuroblastoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Ewing Sarcoma, Osteosarcoma, and Bone Marrow Transplant. Dr. Oesterheld is board certified in American Board Of Pediatrics, Pediatric Hematology And Oncology and American Board Of Pediatrics. Dr. Oesterheld is currently accepting new patients.

What are the latest Neuroblastoma Clinical Trials?
A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma

Summary: This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care surgical resection of the primary tumor, radiation, stem cell transplantation, and immunotherapy works for treating children with newly diagnosed high-risk neuroblastoma. Dinutuximab is a monoclonal antibody that binds to a molecule called GD2, which is found on the surface of neur...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Study Using Molecular Guided Therapy With Induction Chemotherapy Followed by a Randomized Controlled Trial of Standard Immunotherapy With or Without DFMO Followed by DFMO Maintenance for Newly Diagnosed High-Risk Neuroblastoma

Summary: A prospective open label, multicenter study to evaluate the feasibility and acute toxicity of using molecularly guided therapy in combination with standard therapy followed by a Randomized Controlled Trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for Newly Diagnosed High-Risk Neuroblastoma.

Who are the sources who wrote this article ?

Published Date: March 01, 2011
Published By: National Institutes of Health